In murine models of preeclampsia, pharmacological inhibition or genetic deletion of NLRP3 mitigates hypertension, improves fetal outcomes, and restores spiral artery remodeling—highlighting a causative role for inflammasome-mediated inflammation in vascular maladaptation [89]. This evidence concerns the gene NLRP3 and preeclampsia.